In last trading session, OptimizeRx Corp (NASDAQ:OPRX) saw 0.44 million shares changing hands with its beta currently measuring 1.33. Company’s recent per share price level of $13.64 trading at $0.99 or 7.83% at ring of the bell on the day assigns it a market valuation of $252.27M. That closing price of OPRX’s stock is at a discount of -15.18% from its 52-week high price of $15.71 and is indicating a premium of 72.29% from its 52-week low price of $3.78. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.25 million shares which gives us an average trading volume of 291.33K if we extend that period to 3-months.
For OptimizeRx Corp (OPRX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.29. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.02 in the current quarter.
OptimizeRx Corp (NASDAQ:OPRX) trade information
OptimizeRx Corp’s shares saw a change of 33.59% in year-to-date performance and have moved 5.90% in past 5-day. OptimizeRx Corp (NASDAQ:OPRX) showed a performance of 11.90% in past 30-days. Number of shares sold short was 1.57 million shares which calculate 3.83 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 15 to the stock, which implies a rise of 9.07% to its current value. Analysts have been projecting 15 as a low price target for the stock while placing it at a high target of 15. It follows that stock’s current price would drop -9.97% in reaching the projected high whereas dropping to the targeted low would mean a loss of -9.97% for stock’s current value.
OptimizeRx Corp (OPRX) estimates and forecasts
This year revenue growth is estimated to rise 12.18% from the last financial year’s standing.
7 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 22.26M for the same. And 7 analysts are in estimates of company making revenue of 24.68M in the next quarter. Company posted 18.81M and 21.31M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -36.18% during past 5 years.
OptimizeRx Corp (NASDAQ:OPRX)’s Major holders
Insiders are in possession of 14.98% of company’s total shares while institution are holding 66.27 percent of that, with stock having share float percentage of 77.95%. Investors also watch the number of corporate investors in a company very closely, which is 66.27% institutions for OptimizeRx Corp that are currently holding shares of the company. FIRST LIGHT ASSET MANAGEMENT, LLC is the top institutional holder at OPRX for having 1.83 million shares of worth $18.27 million. And as of 2024-06-30, it was holding 10.0548 of the company’s outstanding shares.
The second largest institutional holder is DIVISADERO STREET CAPITAL MANAGEMENT, LP, which was holding about 1.32 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.2422 of outstanding shares, having a total worth of $13.16 million.
On the other hand, ROYCE FUND-Royce Small-Cap Opportunity Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 523.71 shares of worth $7.14 million or 4.33% of the total outstanding shares. The later fund manager was in possession of 506.69 shares on Mar 31, 2025 , making its stake of worth around $6.91 million in the company or a holder of 4.19% of company’s stock.
